Discovering novel metabolic targets to mitigate cyanide toxicity
发现减轻氰化物毒性的新代谢靶点
基本信息
- 批准号:10241503
- 负责人:
- 金额:$ 35.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-01 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgonistAnimal ModelAntidotesBindingBiologicalBrainCarbonCell Culture TechniquesCitric Acid CycleClinicalCollaborationsCoupledCyanidesCytosolDataDevelopmentDoseDrug FormulationsDrug KineticsEnzymesFoundationsFunctional disorderGeneticGoalsHeartHeme IronHomeostasisInterventionInvestigationLeadLibrariesMammalsMediatingMetabolicMetabolic PathwayMetabolismMitochondriaModelingMolecularMolecular TargetMusNew AgentsOrganOryctolagus cuniculusOxidation-ReductionOxygenPathologicPharmacologyPhysiologyPoisoningReactionResistanceRespirationRoleSeriesSiteSpecificityTestingTherapeuticTissuesToxic effectToxinZebrafishanimal efficacybasecell typeclinical developmentcomplex IVcytochrome c oxidaseexperimental studyfolic acid metabolismglyoxylatelead candidatemetabolic poisonmetabolomicsnovelpleiotropismpreventproduct developmentpyruvate dehydrogenaseresponsesuccesstool
项目摘要
Summary
Cyanide is fundamentally a metabolic toxin. Although it has many known targets, many
of its pathological consequences can be ascribed to inhibition of mitochondrial
respiration through inactivation of Complex IV of the electron transport chain. Given this
prominent role of metabolism in the pathophysiology of cyanide poisoning, we expect
that modulators of metabolism might have potential as therapeutic countermeasures. In
fact, this Center has recently discovered that the metabolite glyoxylate profoundly
mitigates cyanide lethality in zebrafish, mice and rabbits. We propose to build upon this
foundation by defining the metabolic functions of this and other agents and testing the
hypothesis that redox imbalance underlies cyanide toxicity. We have further discovered
that activators and substrates of the TCA cycle also confer cyanide resistance and
propose to further develop such agents as therapeutics as well as complete our highly
focused screen of metabolites and metabolic modulators. We also propose a series of
mechanistic experiments to interrogate the extent to which Complex IV inhibition is the
mechanism of cyanide toxicity and the organs that mediate that toxicity. These studies
will synergize with experiments aimed at understanding the metabolic physiology of
cyanide toxicity and the response to various mitigating approaches. We hypothesize
that a deeper understanding of the metabolic basis of cyanide toxicity and mitigation will
inform a rational approach to countermeasures and their appropriate application.
概括
氰化物从根本上是一种代谢毒素。尽管它有许多已知的目标,但许多
其病理后果可以归因于线粒体的抑制
通过灭活电子传输链复合物IV的呼吸。鉴于此
代谢在氰化物中毒的病理生理学中的重要作用,我们期望
代谢的调节剂可能具有治疗性对策。在
事实,该中心最近发现代谢物乙二醇深刻
减轻斑马鱼,小鼠和兔子中的氰化物致死性。我们建议以此为基础
通过定义该代理和其他代理的代谢功能并测试基础
假设氧化还原不平衡是氰化物毒性的基础。我们进一步发现了
TCA循环的激活剂和底物也赋予氰化物的耐药性和
建议进一步发展诸如治疗剂的代理商,并完成我们的高度
代谢物和代谢调节剂的聚焦屏幕。我们还提出了一系列
询问复杂IV抑制程度的机械实验是
氰化物毒性的机制和介导该毒性的器官。这些研究
将与旨在理解代谢生理的实验协同作用
氰化物的毒性和对各种缓解方法的反应。我们假设
对氰化物毒性和缓解代谢基础的更深入了解将
告知一种合理的对策方法及其适当的应用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jared P Rutter其他文献
Jared P Rutter的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jared P Rutter', 18)}}的其他基金
Mitochondrial Biochemistry: From Mechanisms to Disease
线粒体生物化学:从机制到疾病
- 批准号:
9893007 - 财政年份:2019
- 资助金额:
$ 35.12万 - 项目类别:
Discovering novel metabolic targets to mitigate cyanide toxicity
发现减轻氰化物毒性的新代谢靶点
- 批准号:
10671673 - 财政年份:2019
- 资助金额:
$ 35.12万 - 项目类别:
Mitochondrial Biochemistry: From Mechanisms to Disease
线粒体生物化学:从机制到疾病
- 批准号:
10592253 - 财政年份:2019
- 资助金额:
$ 35.12万 - 项目类别:
Mitochondrial Biochemistry: From Mechanisms to Disease
线粒体生物化学:从机制到疾病
- 批准号:
10372005 - 财政年份:2019
- 资助金额:
$ 35.12万 - 项目类别:
Mitochondrial Biochemistry: From Mechanisms to Disease
线粒体生物化学:从机制到疾病
- 批准号:
10673325 - 财政年份:2019
- 资助金额:
$ 35.12万 - 项目类别:
Discovering novel metabolic targets to mitigate cyanide toxicity
发现减轻氰化物毒性的新代谢靶点
- 批准号:
10426371 - 财政年份:2019
- 资助金额:
$ 35.12万 - 项目类别:
Mitochondrial Biochemistry: From Mechanisms to Disease
线粒体生物化学:从机制到疾病
- 批准号:
10728410 - 财政年份:2019
- 资助金额:
$ 35.12万 - 项目类别:
Discovering novel metabolic targets to mitigate cyanide toxicity
发现减轻氰化物毒性的新代谢靶点
- 批准号:
9981044 - 财政年份:2019
- 资助金额:
$ 35.12万 - 项目类别:
Metabolic regulation of intestinal stem cell homeostasis
肠道干细胞稳态的代谢调节
- 批准号:
10189530 - 财政年份:2018
- 资助金额:
$ 35.12万 - 项目类别:
Metabolic regulation of intestinal stem cell homeostasis
肠道干细胞稳态的代谢调节
- 批准号:
10463558 - 财政年份:2018
- 资助金额:
$ 35.12万 - 项目类别:
相似国自然基金
新型IL2Rβγ激动剂逐级控释联合放疗对抗三阴性乳腺癌的作用及机制研究
- 批准号:82303819
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
负载自组装型非核苷类STING激动剂的亚精胺水凝胶用于抗肿瘤免疫治疗及机制研究
- 批准号:82303561
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
靶向SIRT3小分子激动剂调控三阴性乳腺癌细胞自噬和免疫微环境的机制研究
- 批准号:82373193
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于OSMAC-GNPS分析策略的蚂蚱内生真菌Aspergillus sp.中新颖泛PPAR激动剂的发现及治疗NASH研究
- 批准号:82304340
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
探究FSP1激动剂在治疗肾缺血再灌注损伤中的分子机理与应用
- 批准号:82304600
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Dravet Syndrome Anti-Epileptic Control by Targeting GIRK Channels
通过针对 GIRK 通道进行 Dravet 综合征抗癫痫控制
- 批准号:
10638439 - 财政年份:2023
- 资助金额:
$ 35.12万 - 项目类别:
Prevention of intracellular infection in diabetic wounds by commensal Staphylococcus epidermidis
共生表皮葡萄球菌预防糖尿病伤口细胞内感染
- 批准号:
10679628 - 财政年份:2023
- 资助金额:
$ 35.12万 - 项目类别:
Novel first-in-class Therapeutics for Rheumatoid Arthritis
类风湿关节炎的一流新疗法
- 批准号:
10696749 - 财政年份:2023
- 资助金额:
$ 35.12万 - 项目类别:
The Enteric Glia as a Possible Target for Symptom Relief in Endometriosis
肠胶质细胞作为缓解子宫内膜异位症症状的可能目标
- 批准号:
10625609 - 财政年份:2023
- 资助金额:
$ 35.12万 - 项目类别:
PPARdelta receptors and alcohol use phenotypes
PPARδ 受体和饮酒表型
- 批准号:
10682348 - 财政年份:2023
- 资助金额:
$ 35.12万 - 项目类别: